Steven Cohen's RGNX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 139,791 shares of REGENXBIO Inc. (RGNX) worth $1.17 M, representing 0.00% of the portfolio. First purchased in 2017-Q1, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in RGNX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2021, adding 773,100 shares. Largest reduction occurred in Q2 2021, reducing 742,692 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's REGENXBIO (RGNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly REGENXBIO (RGNX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +106,407 | Add 318.74% | 139,791 | $8.38 |
| Q4 2025 | +33,384 | New Buy | 33,384 | $14.40 |
| Q1 2025 | -200 | Sold Out | 0 | $0.00 |
| Q4 2024 | +200 | New Buy | 200 | $7.73 |
| Q2 2024 | -1,600 | Sold Out | 0 | $0.00 |
| Q1 2024 | +1,600 | New Buy | 1,600 | $21.07 |
| Q3 2023 | -7 | Sold Out | 0 | $0.00 |
| Q2 2023 | +7 | New Buy | 7 | $20.00 |
| Q4 2022 | -18,500 | Sold Out | 0 | $0.00 |
| Q3 2022 | -549,000 | Reduce 96.74% | 18,500 | $26.43 |
| Q2 2022 | +50,233 | Add 9.71% | 567,500 | $24.70 |
| Q1 2022 | +517,267 | New Buy | 517,267 | $33.19 |
| Q3 2021 | -163,608 | Sold Out | 0 | $0.00 |
| Q2 2021 | -742,692 | Reduce 81.95% | 163,608 | $38.85 |
| Q1 2021 | +773,100 | Add 580.41% | 906,300 | $34.11 |
| Q4 2020 | +133,200 | New Buy | 133,200 | $45.36 |
| Q3 2020 | -183,756 | Sold Out | 0 | $0.00 |
| Q2 2020 | +183,756 | New Buy | 183,756 | $36.83 |
| Q3 2017 | -313,586 | Sold Out | 0 | $0.00 |
| Q2 2017 | +290,186 | Add 1240.11% | 313,586 | $19.75 |
| Q1 2017 | +23,400 | New Buy | 23,400 | $19.32 |
Steven Cohen's REGENXBIO Investment FAQs
Steven Cohen first purchased REGENXBIO Inc. (RGNX) in Q1 2017, acquiring 23,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held REGENXBIO Inc. (RGNX) for 21 quarters since Q1 2017.
Steven Cohen's largest addition to REGENXBIO Inc. (RGNX) was in Q1 2021, adding 906,300 shares worth $30.91 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 139,791 shares of REGENXBIO Inc. (RGNX), valued at approximately $1.17 M.
As of the Q1 2026 filing, REGENXBIO Inc. (RGNX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in REGENXBIO Inc. (RGNX) was 906,300 shares, as reported at the end of Q1 2021.